Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by CytochromePon Aug 04, 2017 5:56pm
92 Views
Post# 26549877

RE:RE:RE:RE:RE:RE:RE:RE:RE:Bought

RE:RE:RE:RE:RE:RE:RE:RE:RE:BoughtValue and Growth investing based on detailed fundemental analysis has yet to be beaten by any other model. It's not just about buying and holding, it's about evaluating your portfolio to match your current and future position in life. The whole MJ sector is considered high risk, if you want the chance of a large reward, you have to accept certain levels of risk. If you evaluate your portfolio in the future, close to retirement for example, you might want your potfolio to provide you with a low risk, consistant return.

Holding can be a problem because companies change over time, if you don't like how they're changing, sell. 

Foxx248 wrote: So CytochromeP ... you're saying my approach is better then ... buy and hold. That's been my plan since I first bought this stock in the Spring.


Bullboard Posts